Results 141 to 147 of about 3,528 (147)

Impact of the Sinopharm’s BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UAE)

Vaccine, 2022
Walid Abbas Zaher, Tahir A Rizvi, Farah Mustafa   +2 more
exaly  

Two Cousins with Acute Hemichorea after BBIBP‐CorV (Sinopharm) COVID‐19 Vaccine

Movement Disorders, 2022
Mehri Salari, Masoud Etemadifar
exaly  

Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study

Lancet, The, 2022
Nora Fuentes
exaly  

BBIBP-CorV vaccination accelerates anti-viral antibody responses in heterologous Omicron infection: A retrospective observation study in Shanghai

Vaccine, 2023
Yujie Bao, Zhengrong Zhong, Guanzhu Lu   +2 more
exaly  

Immunogenicity of BNT162b2, BBIBP-CorV, Gam-COVID-Vac and ChAdOx1 nCoV-19 Vaccines Six Months after the Second Dose: A Longitudinal Prospective Study

Vaccines, 2023
Vladimir Petrović, Vladimir Vukovic, Aleksandra Patic   +2 more
exaly  

Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273

Cell Reports Medicine, 2022
exaly  

Safety and immunogenicity of the NVX-CoV2373 vaccine as a booster in adults previously vaccinated with the BBIBP-CorV vaccine

Vaccine
exaly